Sterling expands DR to 14 x 17 format

Article

Film and digital imaging vendor Sterling Diagnostic Imaging willshowcase its latest work in Direct Radiography, a work-in-progresstechnology for direct conversion of x-rays into digital data.Sterling debuted DR at the RSNA meeting last year in the

Film and digital imaging vendor Sterling Diagnostic Imaging willshowcase its latest work in Direct Radiography, a work-in-progresstechnology for direct conversion of x-rays into digital data.Sterling debuted DR at the RSNA meeting last year in the company'sprevious incarnation as Du Pont's Medical Products group (SCAN12/13/95).

Since then, Sterling, of Glasgow, DE, has worked on expandingthe size of the DR detector to 14 x 17 inches, according to DeborahDuBois, senior vice president and business manager of the DR program.Sterling will demonstrate a 14 x 17 version of DR, and is stilltargeting a commercial release date of 1998 for DR products, DuBoissaid.

Other news at Sterling's booth is the company's major investmentin new printing technology. Sterling in October announced a dealwith Polaroid in which Sterling would buy the assets of Polaroid'sHelios dry-process laser imaging technology (SCAN 11/6/96). Sterlingwill take over manufacturing and marketing of Helios printers,although Polaroid will continue to manufacture Helios film. Sterlingplans to begin selling Helios by January.

In addition to Helios, Sterling last month released detailson its work developing a new non-laser dry printer with Tektronix(SCAN 11/20/96). The as-yet unnamed printer is based on ink-jettechnology developed by Tektronix and adapted for the medicalimaging market by Sterling. Shipments of that product, which willoccupy a lower price point than Helios, are expected in the thirdquarter of 1997.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.